Cerebrolysin (60 mg vial)

Cerebrolysin (60 mg vial)

Primary use: Neuroprotection and cognitive support (used internationally for stroke recovery and neurodegenerative conditions)

Mechanism / class: Neurotrophic peptide mixture derived from porcine brain proteins; mimics endogenous neurotrophic factors (e.g., BDNF-like activity)

Key effects:

• Supports neuronal survival and repair

• Promotes neuroplasticity and synaptic formation

• May improve cognitive function in certain neurologic conditions

• Exhibits neuroprotective effects after ischemic injury

Clinical distinction:
Unlike single-molecule peptides, Cerebrolysin is a multi-peptide neurotrophic formulation that acts broadly on brain repair and plasticity pathways. It is not a stimulant, not hormonal, and not a neurotransmitter replacement; its use is more common outside the U.S. and remains condition-specific rather than general wellness-oriented.